Barclays initiated coverage of Scholar Rock (SRRK) with an Overweight rating and $45 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRRK:
- Scholar Rock initiated with an Outperform at Leerink
- Scholar Rock assumed with a Buy at Jefferies
- Scholar Rock publishes SAPPHIRE trial data in The Lancet
- Positive Outlook on Scholar Rock Holdings Due to Innovative Therapies and Strategic Advancements
- Scholar Rock’s Optimistic Earnings Call Highlights Progress